Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Penelope J. Hallett, Simone Engelender, Ole Isacson
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Ruilin Tian, Anthony Abarientos, Jason Hong, et al.
Nature Neuroscience (2021) Vol. 24, Iss. 7, pp. 1020-1034
Open Access | Times Cited: 275
Role of MicroRNAs in Parkinson’s Disease
Suh Yee Goh, Yinxia Chao, S. Thameem Dheen, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5649-5649
Open Access | Times Cited: 168
Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases
Anguo Wu, Xiaogang Zhou, Gan Qiao, et al.
Ageing Research Reviews (2020) Vol. 65, pp. 101202-101202
Closed Access | Times Cited: 156
Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
Eleanor Sinclair, Drupad K. Trivedi, Depanjan Sarkar, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 147
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
Rosalía Fernández‐Calle, Sabine C. Konings, Javier Frontiñán-Rubio, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 142
Plasmalogens, platelet-activating factor and beyond – Ether lipids in signaling and neurodegeneration
Fabian Dorninger, Sonja Forss‐Petter, Isabella Wimmer, et al.
Neurobiology of Disease (2020) Vol. 145, pp. 105061-105061
Open Access | Times Cited: 99
The Role of Cholesterol in α‐Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
Patricia García‐Sanz, Johannes M. F. G. Aerts, Rosario Moratalla
Movement Disorders (2020) Vol. 36, Iss. 5, pp. 1070-1085
Open Access | Times Cited: 89
Cell type-specific lipid storage changes in Parkinson’s disease patient brains are recapitulated by experimental glycolipid disturbance
Oeystein Roed Brekk, Jonathan Roy Honey, Seungil Lee, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 44, pp. 27646-27654
Open Access | Times Cited: 79
Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the “Body-First” Hypothesis
Thomas G. Beach, Charles H. Adler, Lucia I. Sue, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1833-1843
Open Access | Times Cited: 62
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases
T. P. Nhung Nguyen, Mandeep Kumar, Ernesto Fedele, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4718-4718
Open Access | Times Cited: 52
Neuroinflammation in Parkinson’s Disease: From Gene to Clinic: A Systematic Review
Carlos Castillo-Rangel, Gonzalo Núñez Marín, Karla Aketzalli Hernández-Contreras, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5792-5792
Open Access | Times Cited: 27
More than meets the eye in Parkinson’s disease and other synucleinopathies: from proteinopathy to lipidopathy
Manuel Flores‐León, Tiago F. Outeiro
Acta Neuropathologica (2023) Vol. 146, Iss. 3, pp. 369-385
Open Access | Times Cited: 24
FABP5 regulates ROS‐NLRP3 inflammasome in glutamate‐induced retinal excitotoxic glaucomatous model
Zhou Zeng, Mengling You, Cong Fan, et al.
The FASEB Journal (2025) Vol. 39, Iss. 1
Closed Access | Times Cited: 1
Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
Diba Ahmadi Rastegar, Laura P. Hughes, Gayathri Perera, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
JZL-184 Alleviate Neurological Impairment through Regulation of Mitochondrial Transfer and Lipid Droplet Accumulation after Cardiac Arrest
Qiang Zhang, Chenyu Zhang, Yuanzheng Lu, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 7
Relationship between Neuroprotective Effects and Structure of Procyanidins
Juan Chen, Yixuan Chen, Yangfan Zheng, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2308-2308
Open Access | Times Cited: 25
Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson’s disease
Pedro A. B. Pereira, Drupad K. Trivedi, Justin D. Silverman, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 24
Chloramine-T-Enabled Mass Spectrometric Analysis of C═C Isomers of Unsaturated Fatty Acids and Phosphatidylcholines in Human Thyroids
Bo Zhang, Yunjun Wang, Bowen Zhou, et al.
Analytical Chemistry (2022) Vol. 94, Iss. 16, pp. 6216-6224
Closed Access | Times Cited: 23
Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies
Lijun Dai, Miao Liu, Ke Wei, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 5
Proteostasis of α-Synuclein and Its Role in the Pathogenesis of Parkinson’s Disease
Deqiang Han, Wei Zheng, Xueyao Wang, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 35
Prevalence of Parkinson’s Disease in Adults Aged 65 Years and Older in China: A Multicenter Population-Based Survey
Zhengyu Song, Shuai Liu, Xiyu Li, et al.
Neuroepidemiology (2021) Vol. 56, Iss. 1, pp. 50-58
Closed Access | Times Cited: 30
Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease
Joo‐Hyun Park, Chung-Woo Lee, Myung Ji Nam, et al.
Neurology (2021) Vol. 96, Iss. 10
Closed Access | Times Cited: 28
QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study
Hailing Liu, Bin Deng, Hang Zhou, et al.
EClinicalMedicine (2022) Vol. 52, pp. 101615-101615
Open Access | Times Cited: 19
27‐Hydroxycholesterol Drives the Spread of α‐Synuclein Pathology in Parkinson's Disease
Lijun Dai, Jiannan Wang, Xingyu Zhang, et al.
Movement Disorders (2023) Vol. 38, Iss. 11, pp. 2005-2018
Closed Access | Times Cited: 11
Selective diagnostics of Amyotrophic Lateral Sclerosis, Alzheimer’s and Parkinson’s Diseases with machine learning and miRNA
J.H. Lee, Valentina L. Kouznetsova, Santosh Kesari, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top